Nov. 27 2024
Source Page: Eplontersen for treating hereditary transthyretin-related amyloidosisNov. 27 2024
Source Page: Eplontersen for treating hereditary transthyretin-related amyloidosisNov. 27 2024
Source Page: Eplontersen for treating hereditary transthyretin-related amyloidosisNov. 27 2024
Source Page: Eplontersen for treating hereditary transthyretin-related amyloidosisNov. 27 2024
Source Page: Eplontersen for treating hereditary transthyretin-related amyloidosisNov. 27 2024
Source Page: Heart failure with preserved ejection fraction: pathway support toolNov. 26 2024
Source Page: Investment in general practice in England, 2018/19 to 2022/23Nov. 26 2024
Source Page: National dose banding table – teclistamab 90mgmLNov. 26 2024
Source Page: Tobacco: preventing uptake, promoting quitting and treating dependence - Cytisine for smoking cessationNov. 26 2024
Source Page: Molnupiravir for treating COVID-19 [ID6340]